Mankind Pharma Limited — Others, 30-04-2025: Disclosure under SEBI Takeover Regulations

Mankind Pharma Limited's Promoter and Promoter Group have confirmed no encumbrance on their shares for the financial year ended March 31, 2025. This assurance boosts investor confidence by highlighting the stability and security of shareholdings. The lack of encumbrance reflects positive governance and integrity within the company's ownership structure, which may enhance shareholder sentiment and overall trust in the company's management and operations.